ACRS - Aclaris Therapeutics stock spikes after speculation of potential sale

Aclaris Therapeutics (ACRS) jumped 13% after a report that the company hired banks to explore a potential sale.The company allegedly has hired two investments banks to consider a potential sale, according a Street Insider report.Aclaris didn't immediately return Seeking Alpha request for comment.The speculation comes on the same that the company announced it would be participating in a few upcoming sell side conferences. Typically a company that is running a sale process may cancel out of a conference, not announce they will be participating.Recall Jan. 20, Aclaris shares rise 10% after pricing equity offering.

For further details see:

Aclaris Therapeutics stock spikes after speculation of potential sale